PubRank

A Forsgren

Author PubWeight™ 176.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol 1966 9.65
2 Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol 1976 3.13
3 Prevalence of nine different micro-organisms in the female genital tract. A comparison between women from a venereal disease clinic and from a health control department. Br J Vener Dis 1979 2.52
4 Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol 1978 2.37
5 Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun 1974 2.34
6 Protein A mutants of Staphylococcus aureus. J Bacteriol 1971 2.32
7 "Protein A" from Staphylococcus aureus. 3. Reaction with rabbit gamma-globulin. J Immunol 1967 2.22
8 Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology 1974 2.08
9 Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis 1974 2.06
10 Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother 1977 2.04
11 Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus. Acta Pathol Microbiol Scand 1969 1.86
12 Group B streptococci in venereal disease clinic patients. Br J Vener Dis 1975 1.82
13 Protein A from Staphylococcus aureus. VII. Physicochemical and immunological characterization. Acta Pathol Microbiol Scand 1969 1.74
14 Effects of staphylococcal protein A on heat labile opsonins. J Immunol 1974 1.73
15 Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci 1974 1.62
16 Erythromycin-resistant Campylobacters. Lancet 1978 1.56
17 Studies in venereal disease. I. Isolation of L-phase organisms of N. gonorrhoeae from patients with gonorrhoea. Br J Vener Dis 1972 1.55
18 Protein A from Staphylococcus aureus. VI. Reaction with subunits from guinea pig gamma-1- and gamma-2-globulin. J Immunol 1968 1.39
19 Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother 1979 1.38
20 Influence of normal human serum on the determination of trichomonicidal drug concentrations. Br J Vener Dis 1972 1.35
21 Many bacterial species bind human IgD. J Immunol 1979 1.34
22 Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation. Br J Vener Dis 1974 1.33
23 THE EFFECT OF EXERCISE ON RENAL PLASMA FLOW IN NORMAL MALE SUBJECTS. J Clin Invest 1948 1.33
24 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother 1987 1.33
25 Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis 1979 1.28
26 Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br J Vener Dis 1974 1.28
27 Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect 2011 1.27
28 Studies of the alternate pathway in chelated serum. J Lab Clin Med 1975 1.26
29 Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun 1991 1.25
30 Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 2000 1.25
31 Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother 1986 1.24
32 Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol 1990 1.22
33 Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 1987 1.21
34 Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun 1991 1.20
35 Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis 1985 1.20
36 Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol 1986 1.19
37 Protein D, the immunoglobulin D-binding protein of Haemophilus influenzae, is a lipoprotein. Infect Immun 1992 1.18
38 "Protein A" from Staphylococcus aureus. IV. Production of anaphylaxis-like cutaneous and systemic reactions in non-immunized guinea-pigs. J Immunol 1968 1.18
39 Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis 1985 1.16
40 Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do. Antimicrob Agents Chemother 1990 1.16
41 Effect of normally occurring rabbit antibodies on fluorescent-antibody reactions. J Bacteriol 1966 1.15
42 Antimicrobial susceptibility of group B streptococci. Eur J Clin Microbiol 1986 1.14
43 Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun 1994 1.10
44 Tetracyclines and host-defense mechanisms. Antimicrob Agents Chemother 1973 1.10
45 Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application. Acta Pathol Microbiol Immunol Scand B 1982 1.09
46 Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Scand J Gastroenterol 1997 1.07
47 Sexually-transmitted diseases in women. Br J Vener Dis 1974 1.06
48 Antibiotic-host defence interactions in vitro and in vivo. Scand J Infect Dis Suppl 1980 1.04
49 The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J Infect Dis 2001 1.04
50 Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 2001 1.03
51 The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains. Infect Immun 1995 1.03
52 Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 2001 1.02
53 4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat Res 1989 1.02
54 Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 1994 1.01
55 Fragmentation heterogeneity of 23S ribosomal RNA in Haemophilus species. Gene 1999 1.01
56 Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res 1977 1.00
57 Effect of protein A on adsorption of bacteriophages to Staphylococcus aureus. J Virol 1974 1.00
58 Protein D expression promotes the adherence and internalization of non-typeable Haemophilus influenzae into human monocytic cells. Microb Pathog 2001 1.00
59 Antinuclear antibodies during Puva therapy. Acta Derm Venereol 1979 1.00
60 Mycobacterium marinum wrist arthritis: local and systematic dissemination caused by concomitant immunosuppressive therapy. Scand J Infect Dis 1998 1.00
61 Effect of rifampin on the immune response in mice. Infect Immun 1980 0.99
62 Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc Natl Acad Sci U S A 1989 0.99
63 Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J Med Microbiol 1992 0.99
64 Role of protein A in the serum-soft agar technique. Infect Immun 1972 0.99
65 Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology 1994 0.98
66 Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect Immun 1996 0.98
67 Effect of doxycycline on immune response in mice. Infect Immun 1985 0.98
68 Protein A from Staphylococcus aureus. V. Reaction with guinea pig gamma-globulins. J Immunol 1968 0.97
69 Antimicrobial activity of fosfomycin in vitro. J Antimicrob Chemother 1983 0.97
70 Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures. J Infect Dis 1999 0.96
71 Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis Suppl 1985 0.96
72 Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg 1981 0.96
73 Evaluation of culture methods for isolation of group B streptococci. Diagn Microbiol Infect Dis 1987 0.95
74 Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol 1994 0.95
75 Binding of HLA antigen-containing liposomes to bacteria. Proc Natl Acad Sci U S A 1978 0.95
76 Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood. Infect Immun 1983 0.95
77 Pathogenicity of Staphylococcus aureus mutants in general and local infections. Acta Pathol Microbiol Scand B Microbiol Immunol 1972 0.94
78 An IgM monoclonal protein with multiple serological specificities. Clin Exp Immunol 1979 0.93
79 The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infect Immun 1997 0.93
80 Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab 1980 0.93
81 Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection. Clin Diagn Lab Immunol 1995 0.92
82 Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis 1986 0.92
83 Effect of fusidic acid on the immune response in mice. Infect Immun 1980 0.92
84 Human lactoferrin binding in clinical isolates of Staphylococcus aureus. J Med Microbiol 1991 0.92
85 First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia. Eur J Clin Microbiol Infect Dis 1990 0.90
86 Identification and antibiotic prophylaxis of high-risk patients in elective colorectal surgery. World J Surg 1987 0.90
87 Effect of ciprofloxacin on phagocytosis. Eur J Clin Microbiol 1985 0.89
88 Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun 1993 0.89
89 Lactoferrin-binding proteins in Shigella flexneri. Infect Immun 1992 0.89
90 Age-related variations in anti-streptococcal antibody levels. Eur J Clin Microbiol Infect Dis 1989 0.89
91 Prevention of bacteriophage adsorption to Staphylococcus aureus by immunoglobulin G. J Virol 1974 0.89
92 Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS 1990 0.89
93 Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection. Eur J Clin Microbiol 1986 0.89
94 Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol 1987 0.89
95 A short antibiotic course given in conjunction with and after catheter removal consecutive to transurethral prostatic resection. Scand J Urol Nephrol 1984 0.88
96 Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections. J Clin Microbiol 1990 0.88
97 Limited effects of temafloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob Agents Chemother 1994 0.88
98 Antimicrobial agents and host defence. Scand J Infect Dis Suppl 1984 0.87
99 Intra- and interstrain differences of virulence among nontypeable Haemophilus influenzae strains. APMIS 1998 0.87
100 Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS 1991 0.86
101 Effect of alcohol on chemotaxis, adherence and phagocytosis of human polymorphonuclear leucocytes. Acta Med Scand 1978 0.86
102 Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. Scand J Infect Dis 1987 0.86
103 Pneumonia and acute pancreatitis most probably caused by a Legionella longbeachae infection. Scand J Infect Dis 1987 0.86
104 Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob Agents Chemother 1991 0.86
105 Formalin-treated bacteria as selective B cell mitogens: results in primary and acquired immunodeficiencies. Clin Exp Immunol 1981 0.86
106 Inhibition of in vivo leucocyte migration by NSAIDs. Clin Exp Rheumatol 1985 0.85
107 Failure to detect cell-associated enterotoxin B in Staphylococcus aureus by immunofluorescence. Appl Microbiol 1972 0.85
108 Longitudinal study of group B streptococcal carriage during late pregnancy. Scand J Infect Dis 1987 0.85
109 The effect of a short antibiotic course in transurethral prostatic resection. Scand J Urol Nephrol 1984 0.84
110 Selective enhancement of synthesis of interleukin-2 in lymphocytes in the presence of ciprofloxacin. Eur J Clin Microbiol Infect Dis 1990 0.84
111 Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes. Antimicrob Agents Chemother 1998 0.83
112 Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats. APMIS 1996 0.83
113 Specific binding of lactoferrin to Aeromonas hydrophila. FEMS Microbiol Lett 1991 0.83
114 Detection of bacterial interaction with lactoferrin by an enzyme-linked ligand binding assay (ELBA). J Med Microbiol 1992 0.83
115 Formalin-treated bacteria as selective B cell mitogens in the study of lymphocytes from patients with hypogammaglobulinaemia. Clin Exp Immunol 1980 0.83
116 Significance of group B streptococci in urine cultures from males and non-pregnant females. Scand J Infect Dis 1988 0.82
117 Comparison of skin blisters and implanted cotton threads for the evaluation of antibiotic tissue concentrations. Eur J Clin Microbiol 1982 0.82
118 Several factors influencing the colonization of group B streptococci--rectum probably the main reservoir. Scand J Infect Dis 1981 0.82
119 Glycerol-3-phosphate transport in Haemophilus influenzae: cloning, sequencing, and transcription analysis of the glpT gene. Gene 1998 0.82
120 Comparison between lactoferrin and subepithelial matrix protein binding in Staphylococcus aureus associated with bovine mastitis. J Dairy Sci 1991 0.82
121 CP-115,953 stimulates cytokine production by lymphocytes. Antimicrob Agents Chemother 1995 0.82
122 Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteers. Clin Exp Rheumatol 1986 0.82
123 Agglutination of Staphylococcus aureus by rabbit sera. Infect Immun 1972 0.81
124 Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia and Prevotella melaninogenica. Oral Microbiol Immunol 1991 0.81
125 Effect of lactoferrin on interaction of Prevotella intermedia with plasma and subepithelial matrix proteins. Oral Microbiol Immunol 1994 0.80
126 ESGAB breakpoint determination: clarithromycin. Eur J Clin Microbiol Infect Dis 1991 0.80
127 Haemophilus influenzae, Pneumococci, group A streptococci and Staphylococcus aureus: sensitivity of outpatient strains to commonly prescribed antibiotics. Scand J Infect Dis 1982 0.80
128 Tetracycline interference with the bactericidal effect of serum. Nat New Biol 1973 0.80
129 A skin chamber technique for leukocyte migration studies; description and reproducibility. Acta Pathol Microbiol Immunol Scand C 1985 0.80
130 Antibody response to Arcanobacterium haemolyticum infection in humans. J Infect Dis 1997 0.80
131 Bovine lactoferrin receptors in Staphylococcus aureus isolated from bovine mastitis. J Dairy Sci 1991 0.80
132 Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies. Am J Otolaryngol 1996 0.80
133 Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA). Acta Derm Venereol 1985 0.79
134 Bacteria-immunoglobulin-lymphocyte interactions--new aspects. Scand J Infect Dis Suppl 1980 0.79
135 Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983. Acta Otolaryngol Suppl 1984 0.79
136 The effect of antibacterial agents on the association between bacteria and leukocytes. Scand J Infect Dis Suppl 1982 0.79
137 Immunological aspects of humidifier fever. Eur J Clin Microbiol 1984 0.79
138 Evidence that the antibiotic ciprofloxacin counteracts cyclosporine-dependent suppression of cytokine production. Transplantation 1994 0.78
139 A resolved pneumococcal infection protects against nontypeable Haemophilus influenzae: an evaluation of different routes of whole cell immunization in protection against experimental acute otitis media. Int J Pediatr Otorhinolaryngol 1997 0.78
140 Laminin binding to a heat-modifiable outer membrane protein of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1996 0.78
141 Quantitative phagocytosis by human polymorphonuclear leucocytes. Use of radiolabelled emulsions to measure thae rate of phagocytosis. Immunology 1977 0.78
142 Functional properties of polymorphonuclear leukocytes accumulated in a skin chamber. Acta Pathol Microbiol Immunol Scand C 1985 0.78
143 Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish Reference Group for Antibiotics (SRGA and SRGA-M). Scand J Infect Dis Suppl 1997 0.78
144 Role of the 2H4 molecule in the activation of suppressor inducer function. Eur J Immunol 1988 0.78
145 Bacterial load and inflammatory reaction in the bowel wall after colonic obstruction. An experimental study in rats. Eur J Surg 1991 0.78
146 The activity of isoxazolyl penicillins in experimental staphylococcal infection. J Infect Dis 1989 0.77
147 The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children. Scand J Immunol 2005 0.77
148 Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment. Antimicrob Agents Chemother 1997 0.77
149 Faecal carriage of group B streptococci. Eur J Clin Microbiol 1986 0.77
150 Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Scand J Infect Dis 1992 0.77
151 In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. Scand J Infect Dis 1986 0.77
152 Species distribution and antibiotic sensitivity of bacteria isolated pre- and postoperatively from patients undergoing transurethral prostatic resection. Scand J Urol Nephrol 1984 0.77
153 Effects of N-acetylcysteine on human polymorphonuclear leukocytes. APMIS 1989 0.77
154 Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets. Acta Pharm Suec 1974 0.77
155 Experience with a skin chamber technique for leucocyte migration studies. Immunol Lett 1985 0.76
156 A sulfhydryl-rich IgM protein with multiple serological specificities. Clin Exp Immunol 1987 0.75
157 Antibiotic treatment during surgery for diffuse peritonitis: a prospective randomized study comparing the effects of cefuroxime and of a cefuroxime and metronidazole combination. Br J Surg 1985 0.75
158 Inhibitory effects of nasal drops components on granulocyte chemotaxis. Pharmacol Toxicol 1989 0.75
159 Peroperative contamination and anastomotic leakage after resection for left colon stenosis. An experimental study in the rat. Int J Colorectal Dis 1990 0.75
160 Commentary on ciprofloxacin-dependent superinduction of interleukin-2 synthesis and thymidine uptake. Transplantation 1998 0.75
161 Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro. Br J Clin Pharmacol 1982 0.75
162 Penicillinase production in community strains of staphylococcus aureus. Scand J Infect Dis 1977 0.75
163 European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin. Eur J Clin Microbiol Infect Dis 1994 0.75
164 Serologic differentiation of Legionnaires' disease and psittacosis. J Infect Dis 1981 0.75
165 Use of ciprofloxacin in patients undergoing transurethral prostatic surgery. Scand J Infect Dis Suppl 1989 0.75
166 3,4-Dihydroxypyridine: a potential antithyroid drug. Acta Endocrinol (Copenh) 1987 0.75
167 Enhancement of the immunosuppressive effect of cyclosporin A by ciprofloxacin in a rat cardiac allograft transplantation model. Transpl Int 1995 0.75
168 Incidence of Legionella pneumophila in acute lower respiratory tract infections. Scand J Infect Dis 1981 0.75
169 Pathogenicity of protein A mutants of Staphylococcus aureus. Contrib Microbiol Immunol 1973 0.75
170 Rapidly progressing rheumatoid arthritis: an example of polyclonal B-cell activation? Clin Rheumatol 1984 0.75
171 Sensitivity of 523 blood culture isolates to 33 antibiotics. Scand J Infect Dis 1984 0.75
172 Immunofluorescent detection of enterotoxin B from S. aureus. Toxicon 1972 0.75
173 Long-term effects on bacterial sensitivity patterns of preoperative antibiotic prophylaxis in colorectal surgery. Acta Chir Scand 1987 0.75
174 Phagocytosis in mucosal defence. Rhinology 1983 0.75
175 Leukocyte migration in vivo and in vitro in patients with psoriasis. Acta Derm Venereol 1987 0.75
176 [Immunologic and epidemiologic observations on humidifier fever. Complement activation as a cause of local inflammatory symptoms]. Lakartidningen 1985 0.75
177 Effects of in vitro PUVA on human leukocyte function. Br J Dermatol 1984 0.75
178 Effect of Haemophilus influenzae type b conjugate vaccine in combination with peroral immunization with Escherichia coli on experimental otitis media. Int J Pediatr Otorhinolaryngol 1996 0.75
179 Comparative in vitro activity of first, second and third generation cephalosporins. Acta Pathol Microbiol Scand B 1981 0.75
180 The effect of antistaphylococcal agents used alone and in combinations on the survival of Staphylococcus aureus ingested by human polymorphonuclear leukocytes. APMIS 1991 0.75
181 Differences in airway obstruction between heavy smokers. Clin Physiol 1985 0.75
182 Impact of short perioperative courses of cefotaxime on aerobic bacterial flora in patients undergoing transurethral prostatic resection. Eur J Clin Microbiol 1985 0.75
183 Bacterial infection in relation to pain and irregular bleeding in women using IUD. Contraception 1979 0.75
184 Suppressor T lymphocyte function in Graves' disease. Acta Endocrinol (Copenh) 1982 0.75
185 Acute otitis media in older children and adults treated with phenoxymethyl penicillin or erythromycin stearate. Bacteriological and immunological aspects. Acta Otolaryngol 1983 0.75
186 [Complement dependent phagocytosis in idiopathic nephrotic syndrome and in healthy controls]. Lakartidningen 1975 0.75
187 Ciprofloxacin upregulates interleukin-2 at the protein and mRNA levels in murine lymphocytes, but does not shorten graft survival in a rat cardiac allograft transplantation model. Transplant Proc 1992 0.75
188 [Legionnaires' disease in kidney transplanted patient]. Lakartidningen 1979 0.75
189 The immunosuppressive effect of streptozotocin-induced diabetes in rats. Res Exp Med (Berl) 1986 0.75
190 Effect of LTB4 and its isomers on human leucocyte migration into skin chambers. Clin Exp Rheumatol 1987 0.75
191 The effectiveness of a short perioperative course with pivampicillin/pivmecillinam in transurethral prostatic resection: bacteriological results. Scand J Infect Dis 1986 0.75
192 Kinetics of enzymes released from polymorphonuclear leucocytes in a skin chamber. Clin Exp Rheumatol 1986 0.75
193 Long wavelength UV radiation affects chemiluminescence of human polymorphonuclear leucocytes. Photochem Photobiol 1985 0.75
194 Long-term effects on bacterial sensitivity patterns of preoperative antibiotic prophylaxis in colorectal surgery. Scand J Infect Dis Suppl 1988 0.75
195 Acute otitis media in older children and adults treated with penicillin or erythromycin. Acta Otolaryngol Suppl 1984 0.75
196 The effectiveness of a short perioperative course with pivampicillin/pivmecillinam in transurethral prostatic resection: clinical results. Scand J Infect Dis 1986 0.75
197 [Continuous treatment after parenteral cephalosporins. Peroral treatment is not available but temporary alternatives exist]. Lakartidningen 1991 0.75
198 Ciprofloxacin interferes with the immunosuppressive effects of cyclosporin A on cytokine production in vitro. Transplant Proc 1994 0.75
199 ESGAB breakpoint determination: temafloxacin. Eur J Clin Microbiol Infect Dis 1991 0.75